Tokyo, June 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062085) titled 'Liquid Biopsy for Predicting Treatment Response and Prognosis in Pancreatic Cancer Patients Receiving Preoperative Therapy' on June 28.
Study Type:
Observational
Primary Sponsor:
Institute - Kagawa University
Condition:
Condition - Pancreatic cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate whether KRAS gene mutations detected by liquid biopsy can predict the response to neoadjuvant therapy in patients with pancreatic cancer undergoing surgical resection. In addition, this study aims to investigate whether longitudinal monitoring of KRAS mut...